Biotech

All Articles

Former Seagen chief executive officer unveils brand new start-up Ottimo Pharma

.After antibody-drug conjugate (ADC) specialist Seagen was marketed to Pfizer in 2015 for an enormou...

Ironwood creates more bid for $1B GI medication along with brand new subgroup records

.On the heels of a stage 3 win that failed to wow investors, Ironwood Pharmaceuticals is back along ...

Novartis inks $150M offer for autoimmune molecular glue

.Do not stop Monte Rosa Therapies right now. The Boston-based biotech is enjoying after authorizing ...

Jade carves out director group with Chinook vets-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of notable management hirings, shootings and...

Septerna goes social with upsized offering of $288M

.Commemorating his firm's upsized going public (IPO), Septerna CEO Jeffrey Finer sounded the positio...

AbbVie brings in Richter richer, spending $25M to make up breakthrough treaty

.AbbVie has actually returned to the source of its own antipsychotic giant Vraylar seeking one more ...

GenSight enters final weeks of money path as profits stream noses out of scope

.GenSight Biologics is actually weeks off of losing money. Once more. The biotech simply has adequat...

AZ licenses disposed of unusual condition medicine to Monopar Therapeutics

.Monopar Therapeutics is actually bouncing back a drug from the dump of AstraZeneca's unusual diseas...

Arcus' brand new HIF-2a data in kidney cancer mean potential edge over Merck's Welireg, professionals mention

.Along with brand new information out on Arcus Biosciences' speculative HIF-2a prevention, one team ...

Roche bets approximately $1B to grow Dyno genetics therapy distribution pact

.After creating a genetics treatment collaboration along with Dyno Therapies in 2020, Roche is actua...